Cargando…
The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure
Autores principales: | Giraudo, C., Guarnieri, G., Molena, B., Caminati, M., Stramare, R., Vianello, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304153/ https://www.ncbi.nlm.nih.gov/pubmed/35963831 http://dx.doi.org/10.1016/j.pulmoe.2022.07.003 |
Ejemplares similares
-
Prone Positioning Is Safe and May Reduce the Rate of Intubation in Selected COVID-19 Patients Receiving High-Flow Nasal Oxygen Therapy
por: Vianello, Andrea, et al.
Publicado: (2021) -
Accuracy of Nasal Pressure Swing to Predict Failure of High-Flow Nasal Oxygen in Patients with Acute Hypoxemic Respiratory Failure
por: Tonelli, Roberto, et al.
Publicado: (2022) -
High flow nasal cannula oxygen therapy in immunocompromised patients with acute hypoxemic respiratory failure
por: Frat, J-P, et al.
Publicado: (2015) -
Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19
por: Vianello, Andrea, et al.
Publicado: (2022) -
High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure
por: Frat, Jean-Pierre, et al.
Publicado: (2022)